LoginSignup
Resmed logo

Resmed

Stock
Stock
ISIN: US7611521078
Ticker: RMD
US7611521078
RMD

Price

Price

Historical dividends and forecast

All dividend data

Resmed has so far distributed $1.49 in 2024. The next dividend will be paid on 12.12.2024

$1.411

CHART BY

Frequently asked questions

What is Resmed's market capitalization?

The market capitalization of Resmed is $35.46B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Resmed's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Resmed is 32.02. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Resmed?

Resmed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $7.543. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Resmed's stock?

Currently, 12 analysts cover Resmed's stock, with a consensus target price of $213.80. Analyst ratings provide insights into the stock's expected performance.

What is Resmed's revenue over the trailing twelve months?

Over the trailing twelve months, Resmed reported a revenue of $4.81B.

Is Resmed paying dividends?

Yes, Resmed is paying dividends. The next payment is scheduled for 12.12.2024, with an expected amount of .

What is the EBITDA for Resmed?

Resmed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.68B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Resmed?

Resmed has a free cash flow of $1.06B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Resmed's stock?

The 5-year beta for Resmed is 0.68. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Resmed have, and what sector and industry does it belong to?

Resmed employs approximately 9,980 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Resmed's shares?

The free float of Resmed is 145.66M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $35.46B

5Y beta

 0.68

EPS (TTM)

 $7.543

Free Float

 145.66M

P/E ratio (TTM)

 32.02

Revenue (TTM)

 $4.81B

EBITDA (TTM)

 $1.68B

Free Cashflow (TTM)

 $1.06B

Pricing

1D span
$239.95$246.48
52W span
$151.95$260.49

Analyst Ratings

The price target is $213.80 and the stock is covered by 12 analysts.

Buy

8

Hold

3

Sell

1

Information

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.

9,980

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US7611521078

Primary Ticker

RMD

Knockouts

Join the conversation
Sign upLogin